AQST stock icon

Aquestive Therapeutics
AQST

$5.09
2.12%

Market Cap: $463M

 

About: Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

Employees: 135

0
Funds holding %
of 6,710 funds
0
Analysts bullish %
of 4 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

188% more call options, than puts

Call options by funds: $1.9M | Put options by funds: $661K

35% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 23

0.44% more ownership

Funds ownership: 46.22% [Q1] → 46.66% (+0.44%) [Q2]

3% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 31

1% less funds holding

Funds holding: 97 [Q1] → 96 (-1) [Q2]

33% less funds holding in top 10

Funds holding in top 10: 3 [Q1] → 2 (-1) [Q2]

38% less capital invested

Capital invested by funds: $177M [Q1] → $110M (-$66.7M) [Q2]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$9
77%
upside
Avg. target
$9
77%
upside
High target
$9
77%
upside

4 analyst ratings

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Raghuram Selvaraju
36% 1-year accuracy
40 / 110 met price target
77%upside
$9
Buy
Reiterated
14 Aug 2024
JMP Securities
Jason Butler
56% 1-year accuracy
19 / 34 met price target
77%upside
$9
Market Outperform
Reiterated
12 Aug 2024
HC Wainwright & Co.
Raghuram Selvaraju
36% 1-year accuracy
40 / 110 met price target
77%upside
$9
Buy
Reiterated
26 Jul 2024
JMP Securities
Jason Butler
56% 1-year accuracy
19 / 34 met price target
77%upside
$9
Market Outperform
Reiterated
26 Jun 2024

Financial journalist opinion

Based on 3 articles about AQST published over the past 30 days